SQUAMOUS CELL CARCINOMA MOUTH
Clinical trials for SQUAMOUS CELL CARCINOMA MOUTH explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA MOUTH trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA MOUTH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Recruiting nowThis early-stage trial tests a fluorescent dye attached to the cancer drug nivolumab. The dye is meant to make cancer cells glow during surgery, helping surgeons remove them more precisely. The study will enroll 40 people with head and neck cancer who are already scheduled for su…
Matched conditions: SQUAMOUS CELL CARCINOMA MOUTH
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Cancer immunotherapy may weaken bones, new study warns
Knowledge-focused Recruiting nowThis study looks at how immunotherapy drugs (anti-PD-1) affect bone strength in people being treated for cancer. Researchers will measure bone density and blood markers over a year in 25 patients. The goal is to understand if these treatments increase fracture risk, so doctors ca…
Matched conditions: SQUAMOUS CELL CARCINOMA MOUTH
Phase: NA • Sponsor: Jessica Mezzanotte Sharpe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC